Meet the Team

Dr. Stephen Hawser, PhD, CEO of IHMA Europe Sàrl

Stephen is CEO of IHMA Europe Sàrl, a wholly owned subsidiary of International Health Management Associates, Inc. IHMA Europe Sàrl is based in Epalinges, Switzerland and began operations in February 2009. Prior to joining IHMA, Stephen held several key positions in the pharmaceutical industry with focus in antibacterial and antifungal research and development. His 14 years of industry experience has come with his affiliations with Arpida (Switzerland), GlaxoWellcome (Italy), Hoechst Marion Roussel (Paris) and Marion Merrell Dow (Italy). In his most recent position at Arpida he held the position of Director of Microbiology. He was a senior scientist at Glaxo, and lead the antifungal chemotherapy unit at Hoechst Marion Roussel. His first industry position was with Marion Merrell Dow at the Lepetit Natural Products Research Center where he was coordinator of the in vitro microbiology section.

Prior to joining industry, Stephen earned his Bsc (hons) in Microbiology (University of Aberdeen), PhD in biochemical toxicology (University of Dundee) and his post-doctorate on fungal catheter biofilms at the University of Glasgow. Stephen has regularly published at scientific conferences (>250 posters), in international peer-reviewed journals (>50 articles) and is co-inventor of a number of patents. In addition he is a reviewer for multiple journals and is a member of the CLSI quality control working group and has actively participated with regulatory agencies (FDA, EMEA / EUCAST).